Innovating Works

GLYCARDIAL DIAGNOSTICS

Activa
AGLYC: The First In Vitro Diagnostic Device for the Early Detection of Cardiac Ischemia GLYCARDIAL DIAGNOSTICS tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Cardiovascular diseases (CVD) are the leading cause of death/morbidity across the globe, accounting for 31% of all deaths in 2015. In the sa...
2019-04-12 - 2022-06-30 | Financiado
AGLYC: The First In Vitro Diagnostic Device for the Early Detection of Cardiac Ischemia GLYCARDIAL DIAGNOSTICS tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Cardiovascular diseases (CVD) are the leading cause of death/morbidity across the globe, accounting for 31% of all deaths in 2015. Early de...
2018-07-17 - 2018-09-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.